|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01652 FUSEN PHARM
Nominal 
0.900 0.000 (0.000%) Profitability Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| ROAA (%) | -2.693% | -2.673% | 1.342% | 5.802% | 4.568% |
| ROAE (%) | -6.161% | -5.440% | 2.527% | 10.523% | 8.301% |
| Return on Capital Employed (%) | -5.341% | -5.509% | 2.219% | 10.109% | 7.469% |
Margin Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Gross Profit Margin (%) | 52.953% | 45.759% | 54.745% | 54.650% | 52.159% |
| EBITDA Margin (%) | 6.274% | 8.116% | 14.687% | 17.323% | 21.449% |
| Pre-tax Profit Margin (%) | -5.206% | -6.303% | 6.169% | 16.104% | 15.664% |
| Net Profit Margin (%) | -6.414% | -7.037% | 4.316% | 14.405% | 13.116% |
Liquidity Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Current Ratio (X) | 0.853 X | 0.850 X | 1.041 X | 1.206 X | 1.464 X |
| Quick Ratio (X) | 0.610 X | 0.697 X | 0.792 X | 1.013 X | 1.272 X |
Leverage Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Total Liabilities / Total Assets(%) | 58.160% | 54.610% | 46.992% | 46.973% | 42.057% |
| Total Debt / Total Assets (%) | 25.609% | 16.914% | 19.421% | 15.991% | 17.854% |
| Net Debt / Total Assets (%) | 23.015% | 7.426% | 12.880% | -7.938% | -10.291% |
| Total Debt / Shareholders' Funds (%) | 61.065% | 37.185% | 36.569% | 30.101% | 31.183% |
| Long Term Debt / Shareholders' Funds (%) | 18.894% | 0.070% | 11.842% | 3.033% | 2.970% |
| Net Debt / Shareholders' Funds (%) | 54.881% | 16.327% | 24.253% | -14.943% | -17.974% |
| Net Cash / (Debt) ($) | (309.266M) | (100.275M) | (159.625M) | 98.538M | 121.044M |
| Net Cash / (Debt) per share ($) | (0.412) | (0.132) | (0.207) | 0.127 | 0.151 |
| Total Debt / Capital Employed (%) | 50.663% | 36.356% | 32.089% | 28.613% | 29.353% |
| Interest Coverage Ratio (X) | N/A | N/A | 3.886 X | 9.311 X | 7.943 X |
Efficiency Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Inventory Turnover (Day) | 186.797 Day | 159.072 Day | 237.637 Day | 160.209 Day | 214.609 Day |
| Receivables Turnover (Day) | 138.961 Day | 150.218 Day | 161.606 Day | 132.734 Day | 130.141 Day |
| Payables Turnover (Day) | 106.852 Day | 98.617 Day | 99.705 Day | 66.531 Day | 92.516 Day |
| Remarks: | Real time quote last updated: 25/11/2024 07:46 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -36,941,000 |
| %Change | -- |
| EPS / (LPS) | RMB -0.050 |
| NBV Per Share (¥) | RMB 0.694 |